Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Dimerix Bioscience Pty. Ltd.
Dimerix CEO Explains Company's Different Drug Combo R&D Strategy
Global director of content for Informa Pharma Intelligence, Mike Ward, talks to Kathy Harrison, CEO of Australian biotech Dimerix, about the company's unusual business model.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice